Skip to main content

Table 1 Clinical profile of the study population

From: Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro study

Patient clinical characteristics Normal pregnancy Preeclamptic pregnancy
n 21 15
Age (years) 26.3 ± 5.9 23.7 ± 4.5
Body Mass Index (BMI) (kg/m2) 29.8 ± 6.3 29.6 ± 4.6
Birth weight (grams) 3035.4 ± 535.0 2599 ± 697.3a
Gestational age(weeks) 37.8 ± 2.1 s36.6 ± 2.4
Systolic blood pressure (mm Hg) 135 ± 13 174 ± 15b
Diastolic blood pressure (mm Hg) 77 ± 9 110 ± 7b
Mean blood pressure (mm Hg) 96 ± 9 131 ± 8b
Proteinuria (0-4+) none >1+
Number of patients receiving anti-hypertensive medications none 5
  1. Values are expressed as mean ± SD. ap < 0.05, bp < 0.0001 versus normal pregnancy
  2. Anti-hypertensive treatment for five preeclamptic patients included Hydralazine and Labetalol.